Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports | September 25, 2019 |

Biopharma 'Keeps Executing and Securing Milestones'

The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report. In a Dec. 12 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) received U.S. Food and Drug Adminis...
Streetwise Reports | December 19, 2019 |

Trump Impeached in the House! Is It Time for Gold Now?

Last week, the House voted to impeach Donald Trump. This is the third time in the U.S. history such an event has happened to the sitting President. What does it imply for the gold market? Trump’s Impeachment, Explained On Wednesday, the House of Represe...
Arkadiusz Sieron | December 27, 2019 |

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...
Streetwise Reports | January 16, 2020 |

How Technology Helps Build Shareholder Perception

Technology is fundamentally changing business platforms and the way managers and executive directors plan, operate, manage, market, communicate and make a profit in business. In fact, some of the best-known brands and successful entrepreneurs focus on and are driven by t...
Lloyd Ainey | October 1, 2020 |

Tallgrass Energy Shares Rise 20% on Blackstone Partners Acquisition Deal

Shares of Tallgrass Energy LP traded 20% higher after the firm advised that it entered into a definitive merger agreement with Blackstone Infrastructure Partners to acquire all of the company's publicly held outstanding class A shares for $22.45 per share in cash. Mid...
Streetwise Reports | December 18, 2019 |

Remote Patient Monitoring: A Recurring Revenue Business Model that’s Moving Markets

Just about a year ago , we introduced our Stockhouse investor audience to a soon-to-be publicly listed company that was revolutionizing the digital and virtual healthcare space. Fast-forward to today and Cloud DX Inc. ( TSX-V.CDX , OTC: CDXFF , Forum ) is now publicly tr...
Dave Jackson | March 17, 2022 |

Teekay Offshore Shares Spike 30% Higher on Brookfield Merger Agreement

Teekay Offshore Partners shares are trading more than 30% higher today on news that Brookfield Business Partners will be purchasing all un-owned common units of the firm for $1.55 per share. This morning Hamilton, Bermuda based Teekay Offshore Partners L.P. (TOO:NYSE...
Streetwise Reports | October 2, 2019 |

RingCentral's Partnership with Avaya Sends Both Firms Shares Up 25%

Shares of RingCentral and Avaya Holdings are soaring today after the announcement that RingCentral will become Avaya's exclusive Unified Communications as a Service (UCaaS) solutions provider. Yesterday afternoon after the markets closed, RingCentral Inc. (RNG:NYSE) ...
Streetwise Reports | October 8, 2019 |
1 2 3 4